SIRT3 and acute myeloid leukemia: To explore the impact of SIRT3 SUMOylation on AML chemoresistance in vitro, lentivirus encoding vector control, SIRT3 or SIRT3K228R overexpressing MV4-11 cells were treated with the indicated doses of Ara-C for 48 h.